Journal of Clinical Pathways September, 2020
Joel Diamond, MD, FAAFP

Abstract: Many health care leaders find themselves in an unexpected situation as market awareness around precision medicine grows: primary care providers increasingly have become the front line for genetic and genomic testing in their organizations. As a result, clinical leaders are realigning their precision medicine efforts to acknowledge the challenges and optimize the opportunities this paradigm shift represents. To make sure this durable data is able to be understood, shared, and leveraged, health care organizations must consider constructing appropriate and scalable technology systems.

Key Words: genomics, genetic testing, primary care, clinical genetics, health informatics

As market awareness around precision medicine grows, many health care leaders find themselves in an unexpected situation: primary care providers (PCP)—rather than other specialists and subspecialists—increasingly
have...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Physician, Precision Medicine, Primary care, Provider
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article